Minimally invasive aortic valve replacement with an expandable bioprosthesis after LVAD implantation as redo surgery.
Mahmut ÖztürkPetar RisteskiMirko DossAron-Frederik PopovPublished in: The International journal of artificial organs (2022)
Left Ventricular Assist Device (LVAD) is currently implanted not only as a bridge to transplant or recovery but also as destination therapy. One factor, affecting the device performance and treatment adequacy negatively is the development of aortic valve insufficiency (AI) after the implantation. Herein, we introduce a minimally invasive partial sternotomy aortic valve replacement with an expandable bio-prosthesis in a 74-year-old LVAD patient with severe AI.
Keyphrases
- aortic valve replacement
- left ventricular assist device
- minimally invasive
- aortic valve
- transcatheter aortic valve implantation
- aortic stenosis
- transcatheter aortic valve replacement
- artificial intelligence
- robot assisted
- case report
- early onset
- ejection fraction
- left ventricular
- machine learning
- combination therapy
- coronary artery disease
- cell therapy
- drug induced